Try a new search

Format these results:

Searched for:

in-biosketch:true

person:kistei01

Total Results:

280


Comparing dimethyl fumarate efficacy and tolerability among Caucasian-, African- and Hispanic-American MS patients [Meeting Abstract]

Ryerson, LZhovtis; Pandey, K; Sammarco, C; Laing, L; Confident, G; Green, R; Richter, B; Elyashiv, M; Kalina, J; Kister, I
ISI:000365729401024
ISSN: 1477-0970
CID: 1890272

The sound lateralization test demonstrates slowed processing speed in MS patients with minimal to mild disability and shows no learning effects in multiple testing sessions over a 1-year period [Meeting Abstract]

Bacon, J; Bacon, T; Rimler, Z; Kister, I
ISI:000365729401119
ISSN: 1477-0970
CID: 1890312

Stability and prognostic utility of patient-derived MS severity score (P-MSSS) among MS clinic patients [Meeting Abstract]

Kister, I; Bacon, T; Levinas, M; Green, R; Cutter, G; Chamot, E
ISI:000365729401198
ISSN: 1477-0970
CID: 1890322

Harnessing real-time patient data to improve clinical outcomes and research: the multiple sclerosis partners advancing technology and healthcare solutions (MS PATHS) initiative [Meeting Abstract]

Mowry, EM; Bermel, R; Balcer, LJ; Cassard, SD; Fisher, E; Izbudak, I; Jones, S; Kister, I; Krueger, G; Lui, YW; Perryman, J; Sickert, D; Williams, JR; Rudick, R
ISI:000365729401199
ISSN: 1477-0970
CID: 1890332

Assessment of whole brain blood flow changes in multiple sclerosis: phase contrast MRI versus ASL [Meeting Abstract]

Ge, Y; Marshall, O; Kister, I; Lu, H; Sadowski, M; Grossman, RI
ISI:000365729401339
ISSN: 1477-0970
CID: 1890342

SymptoMScreen: a novel tool for rapidly assessing MS symptom severity in 11 domains [Meeting Abstract]

Green, R; Kalina, J; Pandey, K; Kister, I
ISI:000365729402134
ISSN: 1477-0970
CID: 1890362

Longitudinal ultra-high field MRI study of brain lesions in neuromyelitis optica [Meeting Abstract]

Kister, I; Dadon, K; Fox, M; Chawla, S; Dusek, P; Wuerfel, J; Paul, F; Sinnecker, T; Ge, Y
ISI:000365729401307
ISSN: 1477-0970
CID: 1890522

Extending natalizumab treatment up to eight weeks shown safe and effective in patients with multiple sclerosis: updated analysis from an ongoing multicenter study [Meeting Abstract]

Ryerson, LZhovtis; Kister, I; Foley, J; Remington, G; Weinstock-Guttman, B; Pandey, K; Pawate, S; Bomprezzi, R; Smith, D; Hojnacki, D; Kolb, C; Okuda, D; Frohman, T; Kalina, J; Hoyt, T; Green, R; Fox, M; Donnelly, S; Chamot, E; Major, E; Frohman, E
ISI:000365729400015
ISSN: 1477-0970
CID: 2172912

INCOMPLETE SUSAC SYNDROME EXACERBATED AFTER NATALIZUMAB [Editorial]

Ryerson, Lana Zhovtis; Kister, Ilya; Snuderl, Matija; Magro, Cynthia; Bielekova, Bibiana
ISI:000218631300018
ISSN: 2332-7812
CID: 5191822

Adult-onset spastic paraparesis: An approach to diagnostic work-up

Zhovtis Ryerson, Lana; Herbert, Joseph; Howard, Jonathan; Kister, Ilya
Adult-onset, chronic progressive spastic paraparesis may be due to a large number of causes and poses a diagnostic challenge. There are no recent evidence-based guidelines or comprehensive reviews to help guide diagnostic work-up. We survey the literature on chronic progressive spastic paraparesis, with special emphasis on myelopathies, and propose a practical, MRI-based approach to facilitate the diagnostic process. Building on neuro-anatomic and radiographic conventions, we classify spinal MRI findings into six patterns: extradural; intradural/extramedullary; Intramedullary; Intramedullary-Tract specific; Spinal Cord Atrophy; and Normal Appearing Spinal Cord. A comprehensive differential diagnosis of chronic progressive myelopathy for each of the six patterns is generated. We highlight some of the more common and/or treatable causes of progressive spastic paraparesis and provide clinical pointers that may assist clinicians in arriving at the diagnosis. We outline a practical, comprehensive MRI-based algorithm to diagnosing adult-onset chronic progressive myelopathy.
PMID: 25263600
ISSN: 0022-510x
CID: 1259952